Cargando…
Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids
Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors have emerged as anti-hyperglycemic agents that improve glycemic control in type 2 diabetic patients, either as monotherapy or in combination with other antidiabetic drugs. Methods: A novel series of dihydropyrimidine phthalimide hybrids was synth...
Autores principales: | Mourad, Ahmed A. E., Khodir, Ahmed E., Saber, Sameh, Mourad, Mai A. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918823/ https://www.ncbi.nlm.nih.gov/pubmed/33670273 http://dx.doi.org/10.3390/ph14020144 |
Ejemplares similares
-
Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity
por: Mourad, Ahmed A E, et al.
Publicado: (2020) -
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity
por: Mourad, Mai A. E., et al.
Publicado: (2023) -
Design and Synthesis of N-phenyl Phthalimides as Potent Protoporphyrinogen Oxidase Inhibitors
por: Gao, Wei, et al.
Publicado: (2019) -
Discovery of novel phthalimide analogs: Synthesis, antimicrobial and antitubercular screening with molecular docking studies
por: Rateb, Heba S., et al.
Publicado: (2016) -
Novel phthalimide based analogues: design, synthesis, biological evaluation, and molecular docking studies
por: Othman, Ismail M. M., et al.
Publicado: (2019)